EXTRACELLULAR MATRIX CONDITION IN CASE OF HCVASSOCIATED LIVER FIBROSIS

Codice QR

EXTRACELLULAR MATRIX CONDITION IN CASE OF HCVASSOCIATED LIVER FIBROSIS

Imbalance of the proteolysis/antiproteolysis system is known to be among key components of immunofibrogenesis of liver in cases of chronic hepatitis C. To evaluate these aspects, we studied several factors of liver tissue remodeling in blood serum and local samples from HCV patients associated with...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	I. S. Gorelova, L. F. Sklyar, E. V. Markelova, A. I. Simakova, I. V. Zenin
Natura:	Articolo
Lingua:	russo
Pubblicazione:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2017-01-01
Serie:	Медицинская иммунология
Soggetti:	matrix metalloproteinase tissue inhibitor of matrix metalloproteinase chronic hepatitis c liver fibrosis
Accesso online:	https://www.mimmun.ru/mimmun/article/view/1163
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Production of factors involved into fibrosis regulation by various types of human macrophages
di: A. A. Maksimova, et al.
Pubblicazione: (2020-08-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
di: K. P. Lactionov, et al.
Pubblicazione: (2014-07-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
di: Ye. V. Klisho, et al.
Pubblicazione: (2011-02-01)

Parameters of the mmp / timp system in assessing the clinical course of pulmonary tuberculoma
di: D. S. Esmedlyaeva, et al.
Pubblicazione: (2024-04-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
di: V. P. Mikhin, et al.
Pubblicazione: (2022-11-01)

Matrix metalloproteinases and their inhibitors
di: O. S. Grigorkevich, et al.
Pubblicazione: (2019-02-01)

Inflammatory activity and markers of extracellular matrix destruction in pulmonary tuberculoma
di: D. S. Esmedlyaeva, et al.
Pubblicazione: (2020-07-01)

Features of the level of matrix metalloproteinase-2, -3, -9 and tissue inhibitors of metalloproteinases-1, -2, -3, -4 in the aqueous humor of patients with primary open-angle glaucoma
di: V. V. Chernykh, et al.
Pubblicazione: (2022-01-01)

The activity of matrix metalloproteinases and the concentration of their tissue inhibitors in the blood serum of patients with type 2 diabetes mellitus, depending on the stage of compensation of the disease
di: A. V. Zubova, et al.
Pubblicazione: (2021-12-01)

Local proteolytic system indicators as suspective factors of keratolysis development after urgent keratoplasty
di: E. V. Chentsova, et al.
Pubblicazione: (2024-07-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
di: O. O. Portyannikova, et al.
Pubblicazione: (2020-03-01)

MMP14 as a central mediator of TGF-β1−induced extracellular matrix remodeling in graves’ orbitopathy
di: Xing Wang, et al.
Pubblicazione: (2025-07-01)

A Noninvasive Predictors of Significant Histological Activity in Chronic Liver Diseases: The Role of Matrix Metalloproteinases
di: A. V. Yagoda, et al.
Pubblicazione: (2025-05-01)

The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty
di: K. V. Sirotkina, et al.
Pubblicazione: (2023-09-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
di: A. V. Shevchenko, et al.
Pubblicazione: (2023-04-01)

Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy
di: F. M. Bogatyreva, et al.
Pubblicazione: (2022-03-01)

Study of Matrix Metalloproteinases and Their Inhibitors in Blood Serum of Healthy Men of Different Ages Exposed to Risk Factors
di: E. V. Markelova, et al.
Pubblicazione: (2025-04-01)

Dynamics of Matrix Metalloproteinase-9 Levels in the Novel Coronavirus Infection COVID-19
di: A. U. Sabitov, et al.
Pubblicazione: (2024-11-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
di: A. O. Rubanenko, et al.
Pubblicazione: (2018-11-01)

THE ROLE OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS IN THE DEVELOPMENT OF COMPLICATIONS OF KIDNEY DISEASE IN CHILDREN
di: G. A. Sukhanova, et al.
Pubblicazione: (2015-06-01)

Age-associated level of myocardial fibrosis markers and chemokines in patients with acute coronary syndrome
di: O. A. Osipova, et al.
Pubblicazione: (2021-09-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
di: Yu. V. Korenovsky, et al.
Pubblicazione: (2012-09-01)

MARKERS OF CONNECTIVE TISSUE REMODELING IN GENITAL PROLAPSE
di: M. L. Khanzadyan, et al.
Pubblicazione: (2016-09-01)

Genetic and morphological aspects of the enterocutaneous fistula development
di: Yu. Usenko, et al.
Pubblicazione: (2020-09-01)

ПРОГНОЗИРОВАНИЕ ТРАНСФОРМАЦИИ РЕЦИДИВИРУЮЩЕЙ ФОРМЫ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В ХРОНИЧЕСКУЮ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ
di: Н. Е. Григориади, et al.
Pubblicazione: (2014-04-01)

Evaluation of the influence of Inosine pranobex on the matrix protein system in patients with chronic viral cervicitis
di: T. A. Nevezhkina, et al.
Pubblicazione: (2023-06-01)

Clinical and prognostic significance of matrix metalloproteinases in patients with myocardial infarction
di: T. B. Pecherina, et al.
Pubblicazione: (2019-06-01)

ISCHEMIC INJURY OF KIDNEY ALLOGRAFTS AND EXPRESSION OF MATRIX METALLOPROTEINASES
di: M. L. Arefjev, et al.
Pubblicazione: (2011-06-01)

CXCL8, MMP1, MMP2, and FN1 Gene Expression and Tumor Extension in Nasopharyngeal Cancer Patients: A Cross-sectional Study
di: Rahmat Cahyanur, et al.
Pubblicazione: (2023-11-01)

Matrix Metalloproteinases 7 and 10 Are Prognostic Biomarkers for Systemic Cardiovascular Risk in Individuals with Peripheral Artery Disease
di: Ben Li, et al.
Pubblicazione: (2025-06-01)

Magnesium Orotate Influence on Thoracic Aorta in Laboratory Rabbits Receiving Levofloxacin
di: N. V. Izmozherova, et al.
Pubblicazione: (2024-10-01)

The intestinal sutures insufficiency: factors of risk and prognostication, based on genetic investigations
di: O. Yu. Usenko, et al.
Pubblicazione: (2022-12-01)

Inhibition of matrix metalloproteinases: a troubleshooting for dentin adhesion
di: Izadora Quintela Souza de Moraes, et al.
Pubblicazione: (2020-08-01)

ASSESSMENT OF EXTRACELLULAR AND INTRACELLULAR PROTEOLYSIS IN PRETUMOR AND TUMOR DISEASES OF THE LARYNX
di: I. V. Kondakova, et al.
Pubblicazione: (2016-02-01)

Investigation of multinucleation and apoptosis of macrophages of BCG-infected mice and their production of cathepsins and matrix metalloproteinases
di: D. А. Il’in
Pubblicazione: (2024-04-01)

Matrix metalloproteinases in the oral fluid as a characteristic of inflammatory-destructive process in periodontal tissues
di: A.V. Samoilenko, et al.
Pubblicazione: (2022-09-01)

Dynamics of Matrix Metalloproteinases in Local Cold Injury
di: M. I. Mikhailichenko, et al.
Pubblicazione: (2019-11-01)

The role of matrix metalloproteinase-9 and the tissue inhibitor of metalloproteinase — 1 in endogenous uveitis in children
di: M. A. Khrabrova, et al.
Pubblicazione: (2024-03-01)

Matrix Metalloproteinases in Predicting Nonproliferative Diabetic Retinopathy in Old Age
di: O. L. Fabikantov, et al.
Pubblicazione: (2023-01-01)

Matrix metalloproteinases and heat shock proteins on extracellular vesicles in colorectal cancer patients: association with metabolic status
di: N. V. Yunusova, et al.
Pubblicazione: (2022-10-01)